BIOVIE INC. — Investor Relations & Filings
Filings indexed
481
across all filing types
Latest filing
2026-05-11
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BIVI
BioVie Inc. is a clinical-stage biopharmaceutical company that develops drug therapies for chronic debilitating conditions. The company's pipeline focuses on neurological and neurodegenerative disorders as well as advanced liver disease. Its lead drug candidate, bezisterim, is being studied for Alzheimer's disease based on the hypothesis that modulating inflammation and enhancing insulin sensitivity in the brain can improve cognitive function and provide neuroprotection. Other areas of focus include Parkinson's disease, ascites (a common complication of advanced liver cirrhosis), and Long COVID. The company also conducts research into epigenetic mechanisms, such as DNA methylation, to understand gene expression regulation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - BIOVIE INC. (0001580149) (Filer) | 2026-05-11 | English | |
| SCHEDULE 13D - BIOVIE INC. (0001580149) (Subject) | 2026-03-25 | English | |
| 10-Q Filing | 2026-02-06 | English | |
| Director's Dealing 2026 | 2026-01-09 | English | |
| Director's Dealing 2026 | 2026-01-09 | English | |
| Director's Dealing 2026 | 2026-01-09 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 45001021 | 10-Q - BIOVIE INC. (0001580149) (Filer) | 2026-05-11 | English | ||
| 33043004 | SCHEDULE 13D - BIOVIE INC. (0001580149) (Subject) | 2026-03-25 | English | ||
| 30698222 | 10-Q Filing | 2026-02-06 | English | ||
| 12689124 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689125 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689126 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689127 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689128 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689129 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689130 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12689131 | Director's Dealing 2026 | 2026-01-09 | English | ||
|
2025
4 filings
| |||||
| 12689132 | FORM S-8 | 2025-11-25 | English | ||
| 12689133 | Regulatory Filings 2025 | 2025-11-19 | English | ||
| 12689134 | CURRENT REPORT | 2025-11-13 | English | ||
| 12689135 | CURRENT REPORT | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beam Therapeutics Inc.
Develops precision genetic medicines using proprietary base…
|
BEAM | US | Manufacturing |
|
Bedrocan Cannabis Corp.
EU-GMP certified producer of standardized medicinal cannabi…
|
BED | CA | Manufacturing |
|
Beihai Gofar Chuanshan Biological Co., Ltd.
Produces marine biological products and chitin derivatives …
|
600538 | CN | Manufacturing |
|
BEIJING AOSAIKANG PHARMACEUTICAL CO.,LTD
Research-driven pharmaceutical firm specializing in oncolog…
|
002755 | CN | Manufacturing |
|
Beijing Beilu Pharmaceutical Co.,Ltd
Specializes in contrast media, CNS treatments, and metaboli…
|
300016 | CN | Manufacturing |
|
Beijing Biostar Pharmaceuticals Co., Ltd.
Biopharma company using synthetic biology to develop novel …
|
2563 | HK | Manufacturing |
|
Beijing Bohui Innovation Biotechnology Group Co., Ltd
Develops medical diagnostic systems, mass spectrometry, and…
|
300318 | CN | Manufacturing |
|
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD
Develops and produces pharmaceuticals, TCM, health suppleme…
|
000931 | CN | Manufacturing |
|
BEIJING FOYOU PHARMA CO.,LTD
Develops and manufactures APIs and finished generic medicat…
|
601089 | CN | Manufacturing |
|
BEIJING HOTGEN BIOTECH CO., LTD.
Develops and manufactures IVD products and automated analyz…
|
688068 | CN | Manufacturing |
BIOVIE INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35090/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35090 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35090 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35090 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35090}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOVIE INC. (id: 35090)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.